Literature DB >> 31775073

Anti-dipeptidyl-peptidase-like protein 6 encephalitis, a rare cause of reversible rapid progressive dementia and insomnia.

Qinming Zhou1, Xiaodong Zhu2, Huanyu Meng1, Min Zhang3, Sheng Chen4.   

Abstract

Anti-dipeptidyl-peptidase-like protein 6 (DPPX) encephalitis is a rare type of autoimmune encephalitis. We present a case of a 72-year-old male with anti-DPPX encephalitis who developed rapidly progressive cognitive decline, psychiatric and sleep problems, severe abdominal pain and diarrhea. Antibodies against DPPX were positive both in serum and cerebrospinal fluid. 18F-FDG PET-MR imaging indicated hypometabolism in the bilateral temporal lobes and thalamus. No related tumors were found, and the patient responded to immunotherapy without relapse at the 3-year follow-up. The present case enriches the understanding of the clinical, imaging manifestations and prognosis of anti-DPPX encephalitis.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autoimmune encephalitis; DPPX antibody; Neuroimmunology

Mesh:

Substances:

Year:  2019        PMID: 31775073     DOI: 10.1016/j.jneuroim.2019.577114

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  9 in total

1.  Dipeptidyl-peptidase-like protein 6 encephalitis treated with immunotherapy.

Authors:  Lan Ye; Margret Schnegelsberg; Mark Obermann
Journal:  Proc (Bayl Univ Med Cent)       Date:  2020-09-28

2.  Immune Checkpoint Inhibitor Associated Autoimmune Encephalitis, Rare and Novel Topic of Neuroimmunology: A Case Report and Review of the Literature.

Authors:  Yining Gao; Jie Pan; Dingding Shen; Lisheng Peng; Zhifeng Mao; Chunxia Wang; Huanyu Meng; Qinming Zhou; Sheng Chen
Journal:  Brain Sci       Date:  2022-06-13

3.  Anti-dipeptidyl-peptidase-like protein 6 encephalitis with pure cerebellar ataxia: a case report.

Authors:  Jing Lin; Min Zhu; Xiaocheng Mao; Zeqing Jin; Meihong Zhou; Daojun Hong
Journal:  BMC Neurol       Date:  2022-07-01       Impact factor: 2.903

4.  Anti-IgLON5 antibodies cause progressive behavioral and neuropathological changes in mice.

Authors:  You Ni; Yifan Feng; Dingding Shen; Ming Chen; Xiaona Zhu; Qinming Zhou; Yining Gao; Jun Liu; Qi Zhang; Yuntian Shen; Lisheng Peng; Zike Zeng; Dou Yin; Ji Hu; Sheng Chen
Journal:  J Neuroinflammation       Date:  2022-06-11       Impact factor: 9.587

Review 5.  Sleep Disturbances Associated with Neurological Autoimmunity.

Authors:  Michelle F Devine; Erik K St Louis
Journal:  Neurotherapeutics       Date:  2021-03-30       Impact factor: 7.620

Review 6.  Current Nosology of Neural Autoantibody-Associated Dementia.

Authors:  Niels Hansen
Journal:  Front Aging Neurosci       Date:  2021-07-28       Impact factor: 5.750

Review 7.  Rapidly progressive dementia and intractable diarrhea: a teaching case report and a systematic review of cognitive impairment in Whipple's disease.

Authors:  Arianna Manini; Giacomo Querzola; Carlo Lovati; Leonardo Pantoni
Journal:  Neurol Sci       Date:  2022-01-03       Impact factor: 3.307

8.  Cerebrospinal Fluid Total Tau Protein Correlates With Longitudinal, Progressing Cognitive Dysfunction in Anti-Neural Autoantibody-Associated Dementia and Alzheimer's Dementia: A Case-Control Study.

Authors:  Niels Hansen; Aaron Levin Juhl; Insa Maria Grenzer; Sina Hirschel; Bianca Teegen; Dirk Fitzner; Claudia Bartels; Charles Timäus; Jens Wiltfang; Berend Malchow
Journal:  Front Immunol       Date:  2022-03-03       Impact factor: 7.561

9.  Clinical and imaging analysis to evaluate the response of patients with anti-DPPX encephalitis to immunotherapy.

Authors:  Jun Xiao; Pei-Cai Fu; Zhi-Jun Li
Journal:  BMC Neurol       Date:  2022-04-05       Impact factor: 2.474

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.